Your browser doesn't support javascript.
loading
Bladder cancer survival in patients with NOD2 or CDKN2A variants.
Zlowocka-Perlowska, Elzbieta; van de Wetering, Thierry; Toloczko-Grabarek, Aleksandra; Scott, Rodney J; Lubinski, Jan.
Afiliação
  • Zlowocka-Perlowska E; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • van de Wetering T; These authors contributed equally to this work.
  • Toloczko-Grabarek A; Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, Szczecin, Poland.
  • Scott RJ; These authors contributed equally to this work.
  • Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Oncotarget ; 13: 628-640, 2022.
Article em En | MEDLINE | ID: mdl-35478773
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Neoplasias Renais Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Neoplasias Renais Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article